• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠优先策略,旨在重置我们的思维,以改善血液透析患者钠、水、容量和血压的管理,减轻心血管负担并改善预后。

Sodium First Approach, to Reset Our Mind for Improving Management of Sodium, Water, Volume and Pressure in Hemodialysis Patients, and to Reduce Cardiovascular Burden and Improve Outcomes.

作者信息

Canaud Bernard, Kooman Jeroen, Maierhofer Andreas, Raimann Jochen, Titze Jens, Kotanko Peter

机构信息

School of Medicine, Montpellier University, Montpellier, France.

Global Medical Office, Freseenius Medical Care (FMC)-France, Fresnes, France.

出版信息

Front Nephrol. 2022 Jul 7;2:935388. doi: 10.3389/fneph.2022.935388. eCollection 2022.

DOI:10.3389/fneph.2022.935388
PMID:37675006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10479686/
Abstract

New physiologic findings related to sodium homeostasis and pathophysiologic associations require a new vision for sodium, fluid and blood pressure management in dialysis-dependent chronic kidney disease patients. The traditional dry weight probing approach that has prevailed for many years must be reviewed in light of these findings and enriched by availability of new tools for monitoring and handling sodium and water imbalances. A comprehensive and integrated approach is needed to improve further cardiac health in hemodialysis (HD) patients. Adequate management of sodium, water, volume and hemodynamic control of HD patients relies on a stepwise approach: the first entails assessment and monitoring of fluid status and relies on clinical judgement supported by specific tools that are online embedded in the HD machine or devices used offline; the second consists of acting on correcting fluid imbalance mainly through dialysis prescription (treatment time, active tools embedded on HD machine) but also on guidance related to diet and thirst management; the third consist of fine tuning treatment prescription to patient responses and tolerance with the support of innovative tools such as artificial intelligence and remote pervasive health trackers. It is time to come back to sodium and water imbalance as the root cause of the problem and not to act primarily on their consequences (fluid overload, hypertension) or organ damage (heart; atherosclerosis, brain). We know the problem and have the tools to assess and manage in a more precise way sodium and fluid in HD patients. We strongly call for a sodium first approach to reduce disease burden and improve cardiac health in dialysis-dependent chronic kidney disease patients.

摘要

与钠稳态及病理生理关联相关的新生理学发现,需要对依赖透析的慢性肾病患者的钠、液体及血压管理有新的认识。鉴于这些发现,必须重新审视多年来盛行的传统干体重探寻方法,并借助监测和处理钠水失衡的新工具加以完善。需要一种全面综合的方法来进一步改善血液透析(HD)患者的心脏健康。HD患者钠、水、容量及血流动力学的充分管理依赖于一种循序渐进的方法:首先是评估和监测液体状态,依靠在线嵌入HD机器的特定工具或离线使用的设备所支持的临床判断;其次是主要通过透析处方(治疗时间、HD机器上嵌入的主动工具)以及饮食和口渴管理方面的指导来纠正液体失衡;第三是在人工智能和远程普及健康追踪器等创新工具的支持下,根据患者的反应和耐受性对治疗处方进行微调。现在是时候将钠水失衡视为问题的根源,而不是主要针对其后果(液体过载、高血压)或器官损伤(心脏;动脉粥样硬化、大脑)采取行动了。我们了解问题所在,并且有工具以更精确的方式评估和管理HD患者的钠和液体。我们强烈呼吁采取以钠为先的方法,以减轻依赖透析的慢性肾病患者的疾病负担并改善心脏健康。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/4853684b2620/fneph-02-935388-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/5c342da5e02a/fneph-02-935388-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/90513ff006a6/fneph-02-935388-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/4853684b2620/fneph-02-935388-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/5c342da5e02a/fneph-02-935388-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/90513ff006a6/fneph-02-935388-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/263d/10479686/4853684b2620/fneph-02-935388-g003.jpg

相似文献

1
Sodium First Approach, to Reset Our Mind for Improving Management of Sodium, Water, Volume and Pressure in Hemodialysis Patients, and to Reduce Cardiovascular Burden and Improve Outcomes.钠优先策略,旨在重置我们的思维,以改善血液透析患者钠、水、容量和血压的管理,减轻心血管负担并改善预后。
Front Nephrol. 2022 Jul 7;2:935388. doi: 10.3389/fneph.2022.935388. eCollection 2022.
2
Personalized Management of Sodium and Volume Imbalance in Hemodialysis to Mitigate High Costs of Hospitalization.血液透析中钠和容量失衡的个体化管理,以降低住院费用。
Blood Purif. 2023;52(6):564-577. doi: 10.1159/000530816. Epub 2023 Jun 8.
3
Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities.血液透析患者的液体与血流动力学管理:挑战与机遇
J Bras Nefrol. 2019 Oct-Dec;41(4):550-559. doi: 10.1590/2175-8239-JBN-2019-0135.
4
Quantitative assessment of sodium mass removal using ionic dialysance and sodium gradient as a proxy tool: Comparison of high-flux hemodialysis versus online hemodiafiltration.使用离子透析和钠梯度作为替代工具定量评估钠质量去除:高通量血液透析与在线血液透析滤过的比较。
Artif Organs. 2021 Aug;45(8):E280-E292. doi: 10.1111/aor.13923. Epub 2021 Mar 8.
5
Is high-volume post-dilution haemodiafiltration associated with risk of fluid volume imbalance? A national multicentre cross-sectional cohort study.高容量后稀释血液滤过与液体容量失衡风险相关吗?一项全国多中心横断面队列研究。
Nephrol Dial Transplant. 2019 Dec 1;34(12):2089-2095. doi: 10.1093/ndt/gfz141.
6
Zero Diffusive Sodium Balance in Hemodialysis Provided by an Algorithm-Based Electrolyte Balancing Controller: A Proof of Principle Clinical Study.基于算法的电解质平衡控制器实现血液透析中零扩散钠平衡:一项原理验证临床研究
Artif Organs. 2019 Feb;43(2):150-158. doi: 10.1111/aor.13328. Epub 2018 Sep 27.
7
Dialysate Sodium: Choosing the Optimal Hemodialysis Bath.透析液钠:选择最佳血液透析液。
Am J Kidney Dis. 2015 Oct;66(4):710-20. doi: 10.1053/j.ajkd.2015.03.034. Epub 2015 May 16.
8
Associations between Hemodialysis Facility Practices to Manage Fluid Volume and Intradialytic Hypotension and Patient Outcomes.血液透析中心管理液体量和透析中低血压的实践与患者结局的关联。
Clin J Am Soc Nephrol. 2019 Mar 7;14(3):385-393. doi: 10.2215/CJN.08240718. Epub 2019 Feb 5.
9
Sodium, volume and pressure control in haemodialysis patients for improved cardiovascular outcomes.血液透析患者的钠、容量和血压控制以改善心血管结局。
Nephrol Dial Transplant. 2020 Mar 1;35(Suppl 2):ii23-ii30. doi: 10.1093/ndt/gfaa017.
10
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.强化血液透析、左心室肥厚与心血管疾病。
Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025.

引用本文的文献

1
Experiences of Dietary Management and Social Adaptation in Young End-Stage Renal Disease Maintenance Hemodialysis Patients: A Qualitative Study.青年终末期肾病维持性血液透析患者的饮食管理与社会适应经历:一项定性研究
Patient Prefer Adherence. 2025 Jun 12;19:1731-1745. doi: 10.2147/PPA.S526917. eCollection 2025.
2
Hemodialysis Procedures for Stable Incident and Prevalent Patients Optimize Hemodynamic Stability, Dialysis Dose, Electrolytes, and Fluid Balance.稳定的初诊和复诊患者的血液透析程序可优化血流动力学稳定性、透析剂量、电解质及液体平衡。
J Clin Med. 2024 May 30;13(11):3211. doi: 10.3390/jcm13113211.
3
Digital Health Support: Current Status and Future Development for Enhancing Dialysis Patient Care and Empowering Patients.

本文引用的文献

1
Detection of Hyponatremia Development in Hemodialysis Patients by Routine Automated Conductivity-Based Monitoring.通过基于电导率的常规自动监测检测血液透析患者低钠血症的发生
ASAIO J. 2023 Feb 1;69(2):239-246. doi: 10.1097/MAT.0000000000001737. Epub 2022 Apr 18.
2
Hidden risks associated with conventional short intermittent hemodialysis: A call for action to mitigate cardiovascular risk and morbidity.传统短期间歇性血液透析相关的潜在风险:呼吁采取行动降低心血管风险和发病率。
World J Nephrol. 2022 Mar 25;11(2):39-57. doi: 10.5527/wjn.v11.i2.39.
3
Na is shifted from the extracellular to the intracellular compartment and is not inactivated by glycosaminoglycans during high salt conditions in rats.
数字健康支持:提高透析患者护理水平和赋能患者的现状和未来发展。
Toxins (Basel). 2024 Apr 30;16(5):211. doi: 10.3390/toxins16050211.
4
Modification of Dialysate Na Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na Deposition in Patients on Hemodialysis.透析液钠浓度的改变而非超滤或透析治疗时间影响血液透析患者的组织钠沉积。
Kidney Int Rep. 2024 Feb 9;9(5):1310-1320. doi: 10.1016/j.ekir.2024.02.002. eCollection 2024 May.
5
Changes in serum sodium concentration during hemodialysis is a predictor of mortality and cardio-cerebrovascular event.血清钠浓度在血液透析过程中的变化是死亡率和心脑血管事件的预测因子。
Ren Fail. 2024 Dec;46(1):2338483. doi: 10.1080/0886022X.2024.2338483. Epub 2024 Apr 11.
6
Practical implementation and clinical benefits of the new automated dialysate sodium control biosensor.新型自动透析液钠控制生物传感器的实际应用与临床益处
Clin Kidney J. 2023 Jan 23;16(5):859-867. doi: 10.1093/ckj/sfad013. eCollection 2023 May.
在高盐条件下,大鼠细胞外的钠离子会转移到细胞内,且不会被糖胺聚糖失活。
J Physiol. 2022 May;600(10):2293-2309. doi: 10.1113/JP282715. Epub 2022 Apr 21.
4
Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.与终末期肾病血液透析相关的炎症和心血管疾病
Front Pharmacol. 2022 Feb 10;13:800950. doi: 10.3389/fphar.2022.800950. eCollection 2022.
5
Coronary artery bypass graft surgery stenting for patients with chronic kidney disease and complex coronary artery disease: a systematic review and meta-analysis.慢性肾脏病合并复杂冠状动脉疾病患者的冠状动脉旁路移植术与支架置入术:一项系统评价和荟萃分析
Ther Adv Chronic Dis. 2021 Mar 23;12:2040622321990273. doi: 10.1177/2040622321990273. eCollection 2021.
6
Proportional integral feedback control of ultrafiltration rate in hemodialysis.血液透析中超滤率的比例积分反馈控制。
Int J Artif Organs. 2022 Mar;45(3):271-277. doi: 10.1177/03913988211069395. Epub 2022 Jan 25.
7
Multitargeted interventions to reduce dialysis-induced systemic stress.减少透析引起的全身应激的多靶点干预措施。
Clin Kidney J. 2021 Dec 27;14(Suppl 4):i72-i84. doi: 10.1093/ckj/sfab192. eCollection 2021 Dec.
8
Inferior Vena Cava Collapsibility Index: Clinical Validation and Application for Assessment of Relative Intravascular Volume.下腔静脉塌陷指数:临床验证及其在相对血管内容量评估中的应用。
Adv Chronic Kidney Dis. 2021 May;28(3):218-226. doi: 10.1053/j.ackd.2021.02.003.
9
Prevalence of fluid overload in an urban US hemodialysis population: A cross-sectional study.美国城市血液透析人群中液体超负荷的流行情况:一项横断面研究。
Hemodial Int. 2022 Apr;26(2):264-273. doi: 10.1111/hdi.12986. Epub 2021 Dec 12.
10
The Predialysis Serum Sodium Level Modifies the Effect of Hemodialysis Frequency on Left-Ventricular Mass: The Frequent Hemodialysis Network Trials.透析前血清钠水平改变了血液透析频率对左心室质量的影响:频繁血液透析网络试验。
Kidney Blood Press Res. 2021;46(6):768-776. doi: 10.1159/000519339. Epub 2021 Oct 13.